Protective activity of tuberculosis vaccines
Polak, M.F.
Nederlands Tijdschrift Voor Geneeskunde 116(45): 2059
1972
ISSN/ISBN: 0028-2162 PMID: 4629490 Document Number: 54786
Document emailed within 1 workday
Related Documents
Wu, X.; Yao, G.; Wang, Y. 2001: Evaluation of protective efficacy of two tuberculosis DNA vaccines by lung histopathological analysis Zhonghua Yu Fang Yi Xue Za Zhi 35(6): 384-386Kholodkova, E.V.; Fedotova, I.M.; Stanislavskiĭ, E.S. 1987: Experimental study of the protective activity of vaccines made from 7 Pseudomonas aeruginosa immunotypes Zhurnal Mikrobiologii Epidemiologii i Immunobiologii 8: 47-50
Hart, P.D.arcy 1963: B. C. G. and vole bacillus vaccines in the prevention of tuberculosis in adolescence and early adult life. Third report to the medical research council by their tuberculosis vaccines clinical trials committee Brit Med Jour 5336: 973-978
1998: Development of new vaccines for tuberculosis. Recommendations of the Advisory Council for the Elimination of Tuberculosis (ACET) MMWR. Recommendations and reports: Morbidity and mortality weekly report. Recommendations and reports 47(RR-13): 1-6
Hussein, A.E.-D.; El-Shaib, T.M.; Saoud, S.M.A.; Shalaby, N.A.E.-A.; Sultan, H.; Ragab, A.M. 2007: Protective immune response of Mycoplasma gallisepticum vaccines in poultry Egyptian Journal of Immunology 14(2): 93-99
Kostiukov, V.I.; Iarov, A.I.; Zezerov, E.G. 1982: Structural protective antigens of viruses used for the development of a new type of chemical vaccines Voprosy Virusologii 1: 5-11
Tabche, N.; Petrović, M. 1982: Determination of the protective value of anti-rabies vaccines for human use in international units in the NIH-test Medicinski Pregled 35(9-10): 357-361
Seidler, M.; Gruneberg, W.J.; Kasbohrer, A.; Tenhagen, B.A.; Kuttler, D. 1993: Establishment of vaccination schedules for protective levels of vaccines for the control of Aujeszky's disease in breeding stock Deutsche Tierärztliche Wochenschrift 100(12): 491-495
Karin, N. 2004: Induction of protective therapy for autoimmune diseases by targeted DNA vaccines encoding pro-inflammatory cytokines and chemokines Current Opinion in Molecular Therapeutics 6(1): 27-33
Kallings, L.O.; Olin, P.; Storsaeter, J. 1988: Protective effect of 2 acellular pertussis vaccines in a double-blind placebo controlled clinical trial Lakartidningen 85(22): 1994-1996
Mark Doherty, T. 2004: New vaccines against tuberculosis Tropical Medicine and International Health: Tm and Ih 9(7): 818-826
Lowrie, D.B. 1999: DNA vaccines against tuberculosis Current Opinion in Molecular Therapeutics 1(1): 30-33
Nechaeva, O.B.; Arenskiĭ, V.A. 2001: Effectiveness of tuberculosis vaccines Problemy Tuberkuleza 1: 13-14
Kaufmann, S. 1987: Towards new leprosy and tuberculosis vaccines Microbiological Sciences 4(11): 324-328
Ortona, L.; De Luca, A. 1998: BCG and prospects for new vaccines against tuberculosis Rays 23(1): 225-230
Hussey, G. 2007: Prospects for new tuberculosis vaccines South African Medical Journal 97(10 Pt 2): 1001-1002
Borkow, G.; Bentwich, Z. 2002: Host background immunity and human immunodeficiency virus protective vaccines, a major consideration for vaccine efficacy in Africa and in developing countries Clinical and Diagnostic Laboratory Immunology 9(3): 505-507
McMurray, D.N. 2000: Recent advances in improved tuberculosis vaccines Indian Journal of Pediatrics 67(2 Suppl): S58-S62
Todorova, R. 1973: Lyophilization of viruses and viral vaccines. III. Protective media for the lyophilization of the Komarov and la Soto strains of the Newcastle virus Veterinarno-Meditsinski Nauki 10(5): 49-53
Jones, L.; Tenorio, E.; Gorham, J.; Yilma, T. 1997: Protective vaccination of ferrets against canine distemper with recombinant pox virus vaccines expressing the H or F genes of rinderpest virus American Journal of Veterinary Research 58(6): 590-593